Epitracker, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Oct 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Oct 9, 2027The maintenance fee for Fatty Acid Analogs and Their Use in the Treatment of Conditions Related to Metabolic Syndrome (US 11,951,088) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,792,266 | Fatty Acid Analogs and Their Use in the Treatment of Conditions Related to Metabolic Syndrome In force · High confidence | In force | High confidence | |
| US 11,951,088 | Fatty Acid Analogs and Their Use in the Treatment of Conditions Related to Metabolic Syndrome In force · Medium confidence | In force | Medium confidence | |
| US 11,992,473 | Compositions and Methods for Diagnosis and Treatment of Conditions Related to the Quality of Aging and Longevity In force · Medium confidence | In force | Medium confidence | |
| US 12,370,166 | Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity In force · From the USPTO record | In force | From the USPTO record | |
| US 12,427,179 | Compositions and methods for diagnosis and treatment of neurodegenerative diseases In force · From the USPTO record | In force | From the USPTO record | |
| US 12,440,473 | Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 3 no status recorded